Skip to main content
. 2016 Jan 4;9:2. doi: 10.1186/s13068-015-0417-6

Fig. 2.

Fig. 2

Initial rate analysis for Agu115 on native and enzyme-treated forms of GAX. Specific activity (µmol min−1 mg−1) for Agu115 acting on these substrates is as follows; GAX: 20.8; GAX pretreated by Xyn10C: 48.8; GAX pretreated by AbfA: 28.9; GAX pretreated by both Xyn10C and AbfA: 52.9. Initial rate of Agu115 activity increases if the GAX is pre-treated by AbfA, Xyn10C, or both